E28.1

Androgen excess

Billable code

This code does not map to a risk-adjusting HCC in the loaded models.

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · E28.1

Use additional

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Synonyms

Hypersecretion of ovarian androgens

Inherited from E28Ovarian dysfunction

Excludes 1

isolated gonadotropin deficiency (E23.0) postprocedural ovarian failure (E89.4-)

Inherited from E20-E35Disorders of other endocrine glands

Excludes 1

galactorrhea (N64.3) gynecomastia (N62)

Inherited from chapter 4Endocrine, nutritional and metabolic diseases

Excludes 1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Official Guidelines for E28.1

FY 2026 ›

I.C.4Chapter-specific guidanceChapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89)

Subsections

Find E28.1 in the alphabetic index

7 index paths lead to this code